Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1.
Postoperative pain slows surgical recovery, impacting the return of normal function for weeks, months, or longer. Here we report the antihyperalgesic actions of a new compound, resolvin D1 (RvD1), known to reduce inflammation and to suppress pain after peripheral nerve injury, on the acute pain occurring after paw incision and the prolonged pain after skin-muscle retraction. Injection of RvD1 (20-40ng) into the L5-L6 intrathecal space 30minutes before surgery reduces the postincisional primary mechanical hypersensitivity, lowering the peak change by approximately 70% (with 40ng) and reducing the area under the curve (AUC) for the entire 10-day postincisional course by approximately 60%. Intrathecal injection of RvD1 on postoperative day (POD) 1 reduces the hyperalgesia to the same level as that from preoperative injection within a few hours, an effect that persists for the remaining PODs. Tactile allodynia and hyperalgesia following the skin/muscle incision retraction procedure, measured at the maximum values 12 to 14days, is totally prevented by intrathecal RvD1 (40ng) given at POD 2. However, delaying the injection until POD 9 or POD 17 results in RvD1 causing only transient and incomplete reversal of hyperalgesia, lasting for <1day. These findings demonstrate the potent, effective reduction of postoperative pain by intrathecal RvD1 given before or shortly after surgery. The much more limited effect of this compound on retraction-induced pain, when given 1 to 2weeks later, suggests that the receptors or pathways for resolvins are more important in the early than the later stages of postoperative pain. Single intrathecal injections of resolvin D1 in rats before or 1 to 2days after surgery strongly reduce postoperative pain for several weeks.
Pain Research Center, Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesia, Peri-operative and Pain Medicine, Brigham and Women's Hospital, Boston, MA, USA Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Liang
L
Huang
Chi-Fei
CF
Wang
Charles N
CN
Serhan
Gary
G
Strichartz
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004281:Docosahexaenoic Acids / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006930:Hyperalgesia / Q000188:drug therapy; D007278:Injections, Spinal / Q000379:methods; D008297:Male; D010147:Pain Measurement / Q000379:methods; D017288:Pain Threshold / Q000187:drug effects; D010149:Postoperative Pain / Q000188:drug therapy* / Q000517:prevention & control*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012867:Skin / Q000294:innervation / Q000503:physiopathology
D000893:Anti-Inflammatory Agents; C518399:resolvin D1; D004281:Docosahexaenoic Acids
Clin J Pain. 2003 Jan-Feb;19(1):48-54
12514456
Neuroscience. 2010 Aug 25;169(2):843-54
20493931
Anesthesiology. 1998 Jan;88(1):143-56
9447867
Pain. 2002 Nov;100(1-2):65-76
12435460
Eur J Pain. 2009 Sep;13(8):820-8
19081275
Pain. 2007 Dec 15;133(1-3):161-73
17467172
Pain. 2003 Sep;105(1-2):97-107
14499425
J Immunol. 2008 Dec 15;181(12):8677-87
19050288
Nat Med. 2010 May;16(5):592-7, 1p following 597
20383154
J Biol Chem. 2003 Apr 25;278(17):14677-87
12590139
Anesthesiology. 2005 Jan;102(1):141-51
15618798
Anesthesiology. 2000 Oct;93(4):1123-33
11020770
Pain. 2003 May;103(1-2):21-9
12749955
Anesthesiology. 2002 Dec;97(6):1591-6
12459689
J Pain. 2004 Apr;5(3):157-63
15106128
Pain. 2009 Jan;141(1-2):88-96
19058913
Pain. 1996 Mar;64(3):493-502
8783314
Can J Anaesth. 1999 Dec;46(12):1127-32
10608205
Brain Res Rev. 2009 Apr;60(1):135-48
19150373
J Pain. 2006 Oct;7(10):768-77
17018337
Nat Neurosci. 1999 Dec;2(12):1114-9
10570489
Lancet. 2006 May 13;367(9522):1618-25
16698416
Pain. 2008 Mar;135(1-2):119-30
17590272
J Comp Neurol. 1979 May 1;185(1):211-20
429615
Anesthesiology. 2004 Aug;101(2):468-75
15277931
Anesthesiology. 2009 Jan;110(1):140-9
19104181
Anesthesiology. 2010 Mar;112(3):511-3
20124975
Anesthesiology. 2008 Jun;108(6):1100-8
18497612
Anesthesiology. 2005 Jul;103(1):113-25
15983463
Anesthesiology. 2011 Jan;114(1):135-49
21169797
Anesthesiology. 1993 Nov;79(5):993-1002; discussion 28A
8239018
Neurosci Lett. 2010 Jun 14;477(1):43-7
20417687
Pain. 2009 Jan;141(1-2):41-51
19010598
Pain. 2008 Aug 31;138(2):380-391
18316159
J Pain. 2007 Jan;8(1):59-66
16949881
J Neurophysiol. 2002 Feb;87(2):712-20
11826040
Mol Pharmacol. 2010 Feb;77(2):185-94
19917879
J Exp Med. 2002 Oct 21;196(8):1025-37
12391014
Nat Rev Immunol. 2008 May;8(5):349-61
18437155
J Comp Neurol. 1985 Jan 1;231(1):66-77
3968229
Pain. 2005 Mar;114(1-2):195-202
15733645
Biochemistry. 1993 Jun 29;32(25):6313-9
8518275
Anesthesiology. 2007 Jul;107(1):128-35
17585224
J Neurophysiol. 2002 Feb;87(2):721-31
11826041
Br J Pharmacol. 2010 Oct;161(3):707-20
20880407
Neuroscientist. 2004 Feb;10(1):40-52
14987447
J Neurosci. 2009 Apr 1;29(13):4096-108
19339605
Pharmacol Ther. 2010 Apr;126(1):56-68
20117131
Nature. 2007 Jun 14;447(7146):869-74
17568749
PLoS One. 2010 May 28;5(5):e10891
20531936